Angiotensin converting enzyme inhibitors in diabetes: Experimental and human experience

Postgraduate Medical Journal

Volumn 62, Issue SUPPL. 1, 1986, Pages 59-64

  Rett, K ^a   Jauch, K W ^a   Wicklmayr, M ^a   Dietze, G ^b   Fink, E ^b   Mehnert, H ^b  

^a Klinikum Schwabing   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN; KALLIKREIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG THERAPY; ENDOCRINE SYSTEM; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REVIEW; THERAPY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; BRADYKININ; CAPTOPRIL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HUMANS; KININS; MALE; METABOLIC CLEARANCE RATE; RATS; RATS, INBRED STRAINS;

EID: 0022515368     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)